Ledger.Open graph →
SEC Form D · filed October 8, 2014

Aclaris Therapeutics, Inc

Offering
$21.3M
Sold
$10.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Ketan Patel · Cambridge, MADirectorRaymond Martin · Santa Clara, CADirectorItai Danino · San Francisco, CAExec · DirectorAnand Mehra · Menlo Park, CADirectorJustin G. Gorenkoff · New York, NYExec · DirectorLee Taylor · Boston, MAExecChristopher Powala · Malvern, PAExecFrank D. Ruffo · Malvern, PAExecEden Shochat · San Francisco, CAExecBen Rubin · San Francisco, CADirectorStuart Browne · SCOTTSDALE, AZExecIndia GP LLC · Santa Monica, CAExec · DirectorKamil D. Ali-Jackson · Malvern, PAExecDaniel G. Goldberg · New York, NYExec · DirectorAnand Mehra · BRANFORD, CTDirectorAlbert Cha · Palo Alto, CADirectorBill Mccullen · Boston, MADirectorNeal Walker · Malvern, PAExec · DirectorStephen A. Tullman · Malvern, PADirectorStuart D. Shanler · Malvern, PAExecJonathan R. Baldwin · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗